Halting targeted and collateral damage to red blood cells by the complement system
Jalink, M., de Boer, E. C. W., Evers, D., Havinga, M. Q., Vos, J. M. I., Zeerleder, S., de Haas, M., Jongerius, I.
Published in Seminars in immunopathology (01.12.2021)
Published in Seminars in immunopathology (01.12.2021)
Get full text
Journal Article
P1530: PERITRANFUSIONAL C1‐INHIBITOR IN PATIENTS WITH SEVERE COMPLEMENT‐MEDIATED AUTOIMMUNE HEMOLYTIC ANEMIA: AN OPEN LABEL PHASE 2 TRIAL
Boer, E. C. W., Jalink, M., Delvasto‐Nuñes, L., Meulenbroek, E. M., Baas, I., Janssen, S. R., Dijkman, E. E., Gelderman, K. A., Wouters, D., Engel, M. D., Haas, M., Kersten, M.‐J., Jongerius, I., Zeerleder, S., Vos, J. M.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article